{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:45:41Z","timestamp":1782776741048,"version":"3.54.5"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.clp.2019.02.008","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T08:28:55Z","timestamp":1553934535000},"page":"187-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Magnesium Sulfate and Novel Therapies to Promote Neuroprotection"],"prefix":"10.1016","volume":"46","author":[{"given":"Rebecca A.","family":"Jameson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene B.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clp.2019.02.008_bib1","first-page":"1","article-title":"Births: final data for 2010","volume":"61","author":"Martin","year":"2012","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.clp.2019.02.008_bib2","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.8546.1","article-title":"Perinatal neuroprotection update","volume":"5","author":"Jelin","year":"2016","journal-title":"F1000Res"},{"issue":"8","key":"10.1016\/j.clp.2019.02.008_bib3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1017\/S001216220500112X","article-title":"Proposed definition and classification of cerebral palsy, April 2005","volume":"47","author":"Bax","year":"2005","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"10.1016\/j.clp.2019.02.008_bib4","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1542\/peds.110.6.1220","article-title":"Trends in the prevalence of cerebral palsy in a population-based study","volume":"110","author":"Winter","year":"2002","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.clp.2019.02.008_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0004-9514(14)60183-5","article-title":"The epidemiology and causes of cerebral palsy","volume":"49","author":"Reddihough","year":"2003","journal-title":"Aust J Physiother"},{"issue":"4","key":"10.1016\/j.clp.2019.02.008_bib6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ana.410440413","article-title":"Neonatal cytokines and coagulation factors in children with cerebral palsy","volume":"44","author":"Nelson","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clp.2019.02.008_bib7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1469-8749.1993.tb11688.x","article-title":"Preterm birth and cerebral palsy: is tumor necrosis factor the missing link?","volume":"35","author":"Leviton","year":"1993","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.clp.2019.02.008_bib8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pediatrneurol.2008.09.016","article-title":"Role of perinatal inflammation in cerebral palsy","volume":"40","author":"Girard","year":"2009","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.clp.2019.02.008_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1203\/00006450-199707000-00001","article-title":"Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn","volume":"42","author":"Dammann","year":"1997","journal-title":"Pediatr Res"},{"issue":"7","key":"10.1016\/j.clp.2019.02.008_bib10","article-title":"Current and emerging therapies in the management of hypoxic ischemic encephalopathy in neonates","volume":"5","author":"Nair","year":"2018","journal-title":"Children (Basel)"},{"issue":"3","key":"10.1016\/j.clp.2019.02.008_bib11","first-page":"57","article-title":"Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment\u2013United States, 2003","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.clp.2019.02.008_bib12","doi-asserted-by":"crossref","first-page":"542.e1-7","DOI":"10.1016\/j.ajog.2011.09.004","article-title":"Magnesium sulfate therapy for the prevention of cerebral palsy in preterm infants: a decision-analytic and economic analysis","volume":"205","author":"Cahill","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.clp.2019.02.008_bib13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/dmcn.13653","article-title":"Economic evaluation and cost of interventions for cerebral palsy: a systematic review","volume":"60","author":"Shih","year":"2018","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"10.1016\/j.clp.2019.02.008_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1542\/peds.95.2.263","article-title":"Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?","volume":"95","author":"Nelson","year":"1995","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.clp.2019.02.008_bib15","first-page":"201","article-title":"The possible role of magnesium in protection of premature infants from neurological syndromes and visual impairments and a review of survival of magnesium-exposed premature infants","volume":"12","author":"Caddell","year":"1999","journal-title":"Magnes Res"},{"issue":"11","key":"10.1016\/j.clp.2019.02.008_bib16","article-title":"Magnesium sulphate and other anticonvulsants for women with pre-eclampsia","author":"Duley","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.clp.2019.02.008_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001060.pub2","article-title":"Magnesium sulphate for preventing preterm birth in threatened preterm labour","author":"Crowther","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.clp.2019.02.008_bib18","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/01.AOG.0000236445.18265.93","article-title":"Magnesium sulfate tocolysis: time to quit","volume":"108","author":"Grimes","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.clp.2019.02.008_bib19","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1067\/mob.2002.123544","article-title":"Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants","volume":"186","author":"Mittendorf","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.008_bib20","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1001\/jama.290.20.2669","article-title":"Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial","volume":"290","author":"Crowther","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.clp.2019.02.008_bib21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-0528.2006.01162.x","article-title":"Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial*","volume":"114","author":"Marret","year":"2007","journal-title":"BJOG"},{"issue":"9","key":"10.1016\/j.clp.2019.02.008_bib22","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa0801187","article-title":"A\u00a0randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy","volume":"359","author":"Rouse","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2019.02.008_bib23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/AOG.0b013e3181ae98c2","article-title":"Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis","volume":"114","author":"Costantine","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.clp.2019.02.008_bib24","article-title":"Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus","author":"Doyle","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.clp.2019.02.008_bib25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/AOG.0b013e3181d4ffa5","article-title":"Committee opinion no. 455: magnesium sulfate before anticipated preterm birth for neuroprotection","volume":"115","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.clp.2019.02.008_bib26","doi-asserted-by":"crossref","first-page":"202.e1-4","DOI":"10.1016\/j.ajog.2011.01.014","article-title":"Magnesium for fetal neuroprotection","volume":"204","author":"Reeves","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.clp.2019.02.008_bib27","article-title":"Different magnesium sulphate regimens for neuroprotection of the fetus for women at risk of preterm birth","author":"Bain","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.clp.2019.02.008_bib28","doi-asserted-by":"crossref","first-page":"e2451","DOI":"10.1097\/MD.0000000000002451","article-title":"Effects and safety of magnesium sulfate on neuroprotection: a meta-analysis based on PRISMA guidelines","volume":"95","author":"Zeng","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.clp.2019.02.008_bib29","doi-asserted-by":"crossref","first-page":"e1002398","DOI":"10.1371\/journal.pmed.1002398","article-title":"Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: an individual participant data meta-analysis","volume":"14","author":"Crowther","year":"2017","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.clp.2019.02.008_bib30","article-title":"Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews","author":"Shepherd","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.clp.2019.02.008_bib31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ajog.2009.04.005","article-title":"Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34\u00a0weeks' gestation: a systematic review and metaanalysis","volume":"200","author":"Conde-Agudelo","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.clp.2019.02.008_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/aji.12118","article-title":"Magnesium sulfate increases intracellular magnesium reducing inflammatory cytokine release in neonates","volume":"70","author":"Suzuki-Kakisaka","year":"2013","journal-title":"Am J Reprod Immunol"},{"issue":"12","key":"10.1016\/j.clp.2019.02.008_bib33","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.4049\/jimmunol.1101765","article-title":"Magnesium decreases inflammatory cytokine production: a novel innate immunomodulatory mechanism","volume":"188","author":"Sugimoto","year":"2012","journal-title":"J\u00a0Immunol"},{"issue":"4","key":"10.1016\/j.clp.2019.02.008_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.315","article-title":"Experimental and clinical evidence of differential effects of magnesium sulfate on neuroprotection and angiogenesis in the fetal brain","volume":"5","author":"Lecuyer","year":"2017","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.clp.2019.02.008_bib35","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1002\/jnr.23091","article-title":"Magnesium sulfate treatment decreases the initial brain damage alterations produced after perinatal asphyxia in fetal lambs","volume":"90","author":"Go\u00f1i-de-Cerio","year":"2012","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.clp.2019.02.008_bib36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0897.2012.01110.x","article-title":"Models of fetal brain injury, intrauterine inflammation, and preterm birth","volume":"67","author":"Burd","year":"2012","journal-title":"Am J Reprod Immunol"},{"issue":"1\u20132","key":"10.1016\/j.clp.2019.02.008_bib37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.eplepsyres.2012.02.004","article-title":"Can magnesium supplementation reduce seizures in people with epilepsy? A hypothesis","volume":"100","author":"Yuen","year":"2012","journal-title":"Epilepsy Res"},{"issue":"4","key":"10.1016\/j.clp.2019.02.008_bib38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nm.2127","article-title":"Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures","volume":"16","author":"Maroso","year":"2010","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.clp.2019.02.008_bib39","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1067\/mob.2002.122421","article-title":"Pharmacokinetics of ionized versus total magnesium in subjects with preterm labor and preeclampsia","volume":"186","author":"Taber","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.clp.2019.02.008_bib40","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/jcph.941","article-title":"Optimization of maternal magnesium sulfate administration for fetal neuroprotection: application of a prospectively constructed pharmacokinetic model to the BEAM cohort","volume":"57","author":"Brookfield","year":"2017","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.clp.2019.02.008_bib41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00003088-197702030-00002","article-title":"Drug kinetics in pregnancy","volume":"2","author":"Krauer","year":"1977","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clp.2019.02.008_bib42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fneur.2018.00247","article-title":"Fetal neuroprotection by magnesium sulfate: from translational research to clinical application","volume":"9","author":"Chollat","year":"2018","journal-title":"Front Neurol"},{"issue":"9","key":"10.1016\/j.clp.2019.02.008_bib43","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/00016340600756896","article-title":"Adverse maternal and neonatal outcome of prolonged course of magnesium sulfate tocolysis","volume":"85","author":"Nassar","year":"2006","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"10.1016\/j.clp.2019.02.008_bib44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1471-0528.2006.01165.x","article-title":"The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18\u00a0months","volume":"114","year":"2007","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.clp.2019.02.008_bib45","article-title":"Practice bulletin no. 171: management of preterm labor","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.clp.2019.02.008_bib46","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.semperi.2015.12.002","article-title":"Stem cell-based therapies for the newborn lung and brain: possibilities and challenges","volume":"40","author":"Mitsialis","year":"2016","journal-title":"Semin Perinatol"},{"issue":"8","key":"10.1016\/j.clp.2019.02.008_bib47","doi-asserted-by":"crossref","first-page":"e73031","DOI":"10.1371\/journal.pone.0073031","article-title":"Mesenchymal stem cells induce T-cell tolerance and protect the preterm brain after global hypoxia-ischemia","volume":"8","author":"Jellema","year":"2013","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.clp.2019.02.008_bib48","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/pr.2017.260","article-title":"Future perspectives of cell therapy for neonatal hypoxic-ischemic encephalopathy","volume":"83","author":"Nabetani","year":"2018","journal-title":"Pediatr Res"},{"issue":"3","key":"10.1016\/j.clp.2019.02.008_bib49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0168-0102(03)00100-7","article-title":"Neonatal hypoxia\u2013ischemia reduces ganglioside, phospholipid and cholesterol contents in the rat hippocampus","volume":"46","author":"Ramirez","year":"2003","journal-title":"Neurosci Res"},{"issue":"8","key":"10.1016\/j.clp.2019.02.008_bib50","doi-asserted-by":"crossref","first-page":"e0183490","DOI":"10.1371\/journal.pone.0183490","article-title":"Adjuvant treatment with monosialoganglioside may improve neurological outcomes in neonatal hypoxic-ischemic encephalopathy: a meta-analysis of randomized controlled trials","volume":"12","author":"Sheng","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.clp.2019.02.008_bib51","article-title":"Creatine for women in pregnancy for neuroprotection of the fetus","author":"Dickinson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"26","key":"10.1016\/j.clp.2019.02.008_bib52","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1523\/JNEUROSCI.1278-04.2004","article-title":"Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice","volume":"24","author":"Zhu","year":"2004","journal-title":"J\u00a0Neurosci"},{"issue":"4","key":"10.1016\/j.clp.2019.02.008_bib53","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3233\/NPM-15915043","article-title":"Safety and efficacy of delayed umbilical cord clamping in multiple and singleton premature infants - a quality improvement study","volume":"8","author":"Ruangkit","year":"2015","journal-title":"J\u00a0Neonatal Perinatal Med"},{"issue":"5","key":"10.1016\/j.clp.2019.02.008_bib54","doi-asserted-by":"crossref","first-page":"676.e1-7","DOI":"10.1016\/j.ajog.2015.07.016","article-title":"Effect of delayed cord clamping on very preterm infants","volume":"213","author":"Chiruvolu","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.008_bib55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jpeds.2016.11.019","article-title":"Safety and short-term outcomes of therapeutic hypothermia in preterm neonates 34-35\u00a0weeks gestational age with hypoxic-ischemic encephalopathy","volume":"183","author":"Rao","year":"2017","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.clp.2019.02.008_bib56","first-page":"9","article-title":"Ischemic conditioning and neonatal hypoxic ischemic encephalopathy: a literature review","volume":"1","author":"Adstamongkonkul","year":"2017","journal-title":"Cond Med"},{"issue":"1","key":"10.1016\/j.clp.2019.02.008_bib57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1474-4422(18)30325-9","article-title":"Magnetic resonance spectroscopy assessment of brain injury after moderate hypothermia in neonatal encephalopathy: a prospective multicentre cohort study","volume":"18","author":"Lally","year":"2019","journal-title":"Lancet Neurol"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510819300193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510819300193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:56:10Z","timestamp":1758815770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510819300193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0095510819300193"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2019.02.008","relation":{},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Magnesium Sulfate and Novel Therapies to Promote Neuroprotection","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2019.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}